In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...

The agency is accused of improperly opposing the rescheduling proposal, conspiring with prohibitionist groups and stacking ...

Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

Pro-cannabis groups allege with new evidence that the agency has actively shown an "unalterably closed mind" toward marijuana ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

The Drug Enforcement Administration (DEA) is facing criticism after failing to release updated annual data on ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

The latest announcement is out from Village Farms International ( (VFF) ).

From policy changes to campaign promises, here are the biggest federal-level cannabis developments from the past year.